{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:45:16Z","timestamp":1782981916891,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Hair loss in adolescents carries significant psychosocial impact, and it is often underrecognized and managed without adolescent-specific approaches. This review describes recent advances in diagnostics, pathophysiology, and therapies to improve diagnosis and management of adolescent alopecia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Trichoscopy and ultraviolet-enhanced follicular dermoscopy improve diagnostic accuracy and reduce invasive testing. Androgenetic alopecia is linked to obesity and genetic predisposition; topical minoxidil remains first-line with low-dose oral minoxidil use supported in some cases. Alopecia areata severity frameworks now include chronicity, relapse, nonscalp involvement, refractoriness, and psychosocial burden. Systemic JAK inhibitors have emerged as treatment options for adolescents with sustained regrowth and patient-reported improvements. Psychogenic hair loss is often comorbid with anxiety, obsessive-compulsive disorder, or attention-deficit\/hyperactivity disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Early, etiology-driven assessment and multidisciplinary care are critical for adolescent hair loss. Adolescent-specific data support more individualized systemic treatments for some types of hair loss, while gaps remain in preventive strategies and long-term outcomes, highlighting priorities for future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001582","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:00:15Z","timestamp":1780509615000},"page":"348-357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment and treatment of adolescent hair loss"],"prefix":"10.1097","volume":"38","author":[{"given":"Adrienne","family":"Conza","sequence":"first","affiliation":[{"name":"UMass Chan Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nujood","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Dermatology Section, Division of Immunology, Boston Children's Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Damji","sequence":"additional","affiliation":[{"name":"Dermatology Section, Division of Immunology, Boston Children's Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jpc.16678","article-title":"Psychosocial impact of alopecia areata in paediatric and adolescent populations: a systematic review","volume":"60","author":"Tan","year":"2024","journal-title":"J Paediatr Child Health"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3928\/19382359-20250321-01","article-title":"Hair loss in teenagers: a review for primary care pediatricians","volume":"54","author":"Garcia","year":"2025","journal-title":"Pediatr Ann"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jdermsci.2021.01.007","article-title":"Telogen Effluvium - a review of the science and current obstacles","volume":"101","author":"Chien Yin","year":"2021","journal-title":"J Dermatol Sci"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"e2024238","DOI":"10.5826\/dpc.1404a238","article-title":"Trichoscopic evaluation of focal non-cicatricial alopecia in Egyptian children","volume":"14","author":"Ahmed","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/pde.70062","article-title":"Insights in trichoscopy: the utility of ultraviolet-induced fluorescence dermoscopy in diagnosis of alopecia areata and tinea capitis in the pediatric population","volume":"42","author":"Daly","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaad.2025.02.002","article-title":"An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia","volume":"92","author":"Lee","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"(Suppl 1)","key":"R7-20260702","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/pde.15842","article-title":"Pathophysiology of alopecia areata in the pediatric patient","volume":"42","author":"Fitzhugh","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40272-026-00738-5","article-title":"Optimizing antifungal therapy for pediatric tinea capitis: a narrative review of species-specific efficacy, dosing strategies, and clinical implications","volume":"28","author":"Tyson","year":"2026","journal-title":"Paediatr Drugs"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2025.3540","article-title":"Approach to scarring alopecia","volume":"161","author":"Wyche","year":"2025","journal-title":"JAMA Dermatol"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"191","DOI":"10.12788\/cutis.1144","article-title":"Clinical, laboratory, and trichoscopic features of pediatric androgenetic alopecia","volume":"114","author":"Lu","year":"2024","journal-title":"Cutis"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"e70167","DOI":"10.1111\/jocd.70167","article-title":"Comprehensive evaluation of androgenetic alopecia: demographic characteristics, psychosocial impact, and the role of social media in treatment choices","volume":"24","author":"Ferhatosmano\u011flu","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2024.4593","article-title":"Low-dose oral minoxidil initiation for patients with hair loss: an international Modified Delphi Consensus Statement","volume":"161","author":"Akiska","year":"2025","journal-title":"JAMA Dermatol"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"1581976","DOI":"10.3389\/fimmu.2025.1581976","article-title":"Correlation between increased total serum IgE levels and clinical features in alopecia areata patients","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"R14-20260702","first-page":"2236","article-title":"The epidemiology of atopic dermatitis among adults and adolescents with alopecia areata in the United States","volume":"S0022-202X","author":"Bunick","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"(Suppl 1)","key":"R15-20260702","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/pde.15838","article-title":"Clinical presentations and comorbidities of pediatric alopecia areata","volume":"42","author":"Mistry","year":"2025","journal-title":"Pediatr Dermatol"},{"issue":"(Suppl 1)","key":"R16-20260702","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/pde.15830","article-title":"Assessment of alopecia areata disease severity in pediatric patients","volume":"42","author":"Sun","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R17-20260702","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamadermatol.2023.5869","article-title":"The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: results from a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity","volume":"160","author":"Moussa","year":"2024","journal-title":"JAMA Dermatol"},{"key":"R18-20260702","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jdv.20526","article-title":"Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: results from the ALLEGRO-LT phase 3, open-label study","volume":"39","author":"Tziotzios","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R19-20260702","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/bjd\/ljae365","article-title":"Efficacy and safety of the oral Janus kinase 3\/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb\/III and long-term phase III clinical studies in alopecia areata","volume":"192","author":"Piliang","year":"2025","journal-title":"Br J Dermatol"},{"key":"R20-20260702","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jdv.20547","article-title":"Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme","volume":"39","author":"King","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-20260702","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40257-024-00899-4","article-title":"Patient-reported hair loss and its impacts as measured by the alopecia areata patient priority outcomes instrument in patients treated with ritlecitinib: the ALLEGRO Phase 2b\/3 randomized clinical trial","volume":"26","author":"Sinclair","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"R22-20260702","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2147\/CCID.S549823","article-title":"Upadacitinib therapy in adolescent severe alopecia areata: a case series and narrative review","volume":"18","author":"Gao","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"R23-20260702","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.3390\/jcm14113881","article-title":"Efficacy of upadacitinib in treating alopecia areata, atopic dermatitis, and Th1 comorbidities in pediatric patients: a comprehensive case series and literature review","volume":"14","author":"Battilotti","year":"2025","journal-title":"J Clin Med"},{"key":"R24-20260702","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/pde.15882","article-title":"Oral tofacitinib for the management of moderate to severe alopecia areata in children and adolescents: a Retrospective study of 36 patients","volume":"42","author":"Mahajan","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R25-20260702","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/bjd\/ljaf088","article-title":"Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib","volume":"193","author":"Mostaghimi","year":"2025","journal-title":"Br J Dermatol"},{"key":"R26-20260702","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2025.05.1387","article-title":"Friend or foe: a systematic review of dupilumab and alopecia areata","volume":"93","author":"Srivatsa","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"R27-20260702","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jdcr.2025.05.048","article-title":"A case series of dupilumab for vitiligo and alopecia areata in the setting of atopic dermatitis","volume":"64","author":"Patel","year":"2025","journal-title":"JAAD Case Rep"},{"key":"R28-20260702","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/ijt.ijt_57_24","article-title":"Frequency of types of alopecia in a single-centre Hair Referral Clinic over a ten years period","volume":"17","author":"Uribe","year":"2025","journal-title":"Int J Trichol"},{"key":"R29-20260702","doi-asserted-by":"crossref","first-page":"e0163725","DOI":"10.1128\/spectrum.01637-25","article-title":"Superficial fungal infections in children in Northern Finland between 2000 and 2021: a single-center study","volume":"13","author":"Korpi","year":"2025","journal-title":"Microbiol Spectr"},{"key":"R30-20260702","doi-asserted-by":"crossref","first-page":"104428","DOI":"10.1016\/j.pdpdt.2024.104428","article-title":"Wood's lamp for early detection of Microsporum Canis tinea capitis in children","volume":"51","author":"Sun","year":"2025","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R31-20260702","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pde.15791","article-title":"Psychiatric comorbidities in pediatric trichotillomania: a multicenter cohort study","volume":"42","author":"Games","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R32-20260702","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamadermatol.2025.3540","article-title":"Approach to scarring alopecia","volume":"161","author":"Wyche","year":"2025","journal-title":"JAMA Dermatol"},{"key":"R33-20260702","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/pde.15864","article-title":"Cicatricial alopecia in the pediatric population: a case series and review of the literature","volume":"42","author":"Carmichael","year":"2025","journal-title":"Pediatr Dermatol"},{"key":"R34-20260702","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40257-025-00960-w","article-title":"Alopecia in children with cancer: a review from pathophysiology to management","volume":"26","author":"Kearney","year":"2025","journal-title":"Am J Clin Dermatol"},{"key":"R35-20260702","doi-asserted-by":"crossref","first-page":"e31432","DOI":"10.1002\/pbc.31432","article-title":"Impact of persistent alopecia on quality of life in childhood cancer and transplant survivors","volume":"72","author":"Kim","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R36-20260702","first-page":"1153","article-title":"Efficacy of scalp cooling to prevent chemotherapy-induced alopecia in children with acute lymphoblastic leukemia: a nonrandomized trial","volume":"33","author":"Kumar","year":"2025","journal-title":"Support Care Cancer"},{"key":"R37-20260702","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00403-025-04300-0","article-title":"Tumor necrosis factor ( inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature","volume":"317","author":"Reiss-Huss","year":"2025","journal-title":"Arch Dermatol Res"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:00:46Z","timestamp":1782979246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001582","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}